Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Sign up for MCHalert eNewsletter

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.

Displaying records 1 through 4 (4 total).

Duckworth K, Gruttadaro D, Markey D. 2010. What families should know about adolescent depression (2nd ed.). Arlington, VA: National Alliance for the Mentally Ill, 36 pp.

Annotation: This guide provides information about adolescent depression and treatment options. It introduces adolescent depression and its causes and symptoms and getting an accurate diagnosis. It then discusses treatment, including talk therapy and medications; risks and benefits of antidepressants, as well as family history and treatment. Risk of suicide is also presented, creating good monitoring systems and safety plans, treatment research, and how to be an effective advocate for an adolescent with depression. The guide concludes with resources.

Contact: National Alliance on Mental Illness, 3803 N. Fairfax Drive, Suite 100, Arlington, VA 22203, Telephone: (703) 524-7600 Secondary Telephone: (800) 950-6264 Fax: (703) 524-9094 E-mail: [email protected] Web Site: http://www.nami.org Available from the website.

Keywords: Adolescents, Advocacy, Antidepressant drugs, Cognitive therapy, Consumer education materials, Depression, Families, Monitoring, Parents, Safety, Treatment

American Psychiatric Association and American Academy of Child and Adolescent Psychiatry. [2005]. The use of medication in treating childhood and adolescent depression: Information for physicians. [No place]: ParentsMedGuide.org, 15 pp.

Annotation: This fact sheet provides physicians with information on the appropriate use of antidepressant medication as a component of a comprehensive treatment program for children and adolescents with depression. The fact sheet includes information about (1) the recent Food and Drug Administration (FDA) decision to require a black box warning for antidepressant medications, (2) the prevalence and impact of child and adolescent depression, (3) an overview of treatment effectiveness of suicidality, (4) what prompted the FDA warning, (5) suicidality in adolescents, (6) recognition and diagnosis of child and adolescent depression, (7) risk factors for suicide, (8) whether talking about suicide signals increased likelihood that a child will hurt him or herself, (9) treating child and adolescent depression, (10) suggestions for physicians when prescribing antidepressant medication to pediatric patients, (11) which medications will carry the warning label, (12) treatment of depression outcome measures, and (13) future directions.

Contact: ParentsMedGuide.org, Web Site: http://www.ParentsMedGuide.org Available from the website.

Keywords: Adolescent health, Antidepressant drugs, Attempted suicide, Child health, Depression, Diagnosis, Drug therapy, Mental health, Pediatricians, Physicians, Risk factors, Suicide, Suicide prevention, Treatment

American Psychiatric Association and American Academy of Child and Adolescent Psychiatry with National Coalition of Concerned Parents, Providers, and Professional Associations. [2005]. The use of medication in treating childhood and adolescent depression: Information for patients and families. [No place]: ParentsMedGuide.org, 9 pp.

Annotation: This fact sheet, geared toward children, adolescents, and families, includes practical advice about treating depression in children and adolescents, as well as information about the recent Food and Drug Administration (FDA) decision to require a black box warning for antidepressant medications. The fact sheet explains (1) what a black box warning is and what prompted the FDA warning, (2) whether antidepressants can help children and adolescents with depression, (3) whether antidepressants increase the risk of suicide, (4) what other factors increase the risk of suicide, (5) whether talking about suicide increases the risk that a child or adolescent will hurt himself, (6) how to be certain that a child or adolescent has depression, (7) what treatment should consist of, (8) how parents can help monitor their child or adolescent, (9) what other treatments are available, (10) whether depression will pass without treatment, (11) whether children or adolescents can continue taking antidepressants currently being prescribed, and (12) how parents can advocate for a child or adolescent who has depression.

Contact: ParentsMedGuide.org, Web Site: http://www.ParentsMedGuide.org Available from the website.

Keywords: Adolescent health, Advocacy, Antidepressant drugs, Attempted suicide, Child health, Consumer education materials, Depression, Diagnosis, Drug therapy, Mental health, Parents, Risk factors, Suicide, Suicide prevention, Treatment

National Institute of Mental Health. 2004. Antidepressant medications for children: Information for parents and caregivers—Statement. Bethesda, MD: National Institute of Mental Health, 3 pp.

Annotation: This fact sheet offers information on antidepressant medication for children to help families and caregivers make treatment choices based on the best currently available information. The fact sheet describes what is known about antidepressant medications, discusses what can be done for a child with depression, and explains what the National Institute of Mental Health is doing to learn more about antidepressant medication for children.

Contact: National Institute of Mental Health, 6001 Executive Boulevard, Bethesda, MD 20892-9663, Telephone: (866) 615-6464 Secondary Telephone: (301) 443-8431 Fax: (301) 443-4279 E-mail: [email protected] Web Site: http://www.nimh.nih.gov Available from the website.

Keywords: Antidepressant drugs, Caregivers, Child health, Depression, Families, Mental health, Research, Treatment
   

The MCH Digital Library is one of six special collections at Geogetown University, the nation's oldest Jesuit institution of higher education. It is supported in part by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under award number U02MC31613, MCH Advanced Education Policy with an award of $700,000/year. The library is also supported through foundation and univerity funding. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.